Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlethora Solutions Holdings Plc Regulatory News (PLE)

  • There is currently no data for PLE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (Plethora Solutions) - Replacement

20 Jan 2016 09:00

RNS Number : 3577M
Regent Pacific Group Limited
20 January 2016
 

AMENDMENT (Section 3)

 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Regent Pacific Group Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Plethora Solutions Holdings plc

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

20 January 2016

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES - Regent Pacific Group Limited

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

86,799,490

10.54

-

-

(2) Cash-settled derivatives:

 

-

-

-

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

-

-

-

-

 

TOTAL:

 

86,799,490

 

10.54

-

-

 

 

Class of relevant security:

 

Warrants 2019

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

12,649,745

12.50

-

-

(2) Cash-settled derivatives:

 

-

-

-

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

-

-

-

-

 

TOTAL:

 

12,649,745

 

12.50

-

-

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

-

Details, including nature of the rights concerned and relevant percentages:

-

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

The directors of Regent Pacific Group Limited and their concert parties have the following holdings in the securities of Plethora Solutions Holdings plc:

 

Director

Held in Own Name, or Concert Party

Number of 1p Ordinary Shares

Notes

James Mellon

Own Name

63,944,045 (7.77%)

(Registered holder is Vidacos Nominees

Limited)

Own Name

1,250,000 (0.15%)

Held by Jim Mellon Retirement Account.

(Registered holder is Pershing Nominees

Limited)

Concert Party:

Galloway Limited

 

82,414,726 (10.01%)

A company wholly owned by a settlement, of which James Mellon is a beneficiary.

(Registered holders are: Vidacos Nominees

Limited (69,414,726) and Pershing Nominees

Limited (13,000,000))

Concert Party:

Port Erin Biopharma Investments Limited

7,750,000 (0.94%)

James Mellon is a 29 per cent. shareholder and the chairman of Port Erin Biopharma Investments Limited.

(Registered holder is NY Nominees Limited)

Concert Party:

Gregory Bailey

555,600 (0.07%)

Held in own name.

TOTAL

157,514,371 (18.94%)

Director

Held in Own Name, or Concert Party

Number of 1p Ordinary Shares

Notes

Mark Searle

 

Own Name

300,000 (0.04%)

Held in own name.

Own Name

1,000,000 (0.12%)

Held by Mark Searle's Self Invested Personal Pension, of which Mark Searle is the sole beneficiary.

Own Name

400,000 (0.05%)

Held by Juliet Mary Druce Searle (Mark Searle's spouse).

TOTAL

1,700,000 (0.21%)

 

The directors of Regent Pacific Group Limited and their concert parties have the following rights to subscribe in the securities of Plethora Solutions Holdings plc:

 

Director

Held in Own Name, or Concert Party

Number of 1p Ordinary Shares

Notes

James Mellon

Own Name

1,000,000 (1.85%)

Entitlement under the Long Term Incentive Plan of Plethora Solutions Holdings plc, under which shares will be granted on a change of control of Plethora Solutions Holdings plc.

Concert Party:

Gregory Bailey

1,000,000 (1.85%)

Entitlement under the Long Term Incentive Plan of Plethora Solutions Holdings plc, under which shares will be granted on a change of control of Plethora Solutions Holdings plc.

TOTAL

2,000,000 (3.69%)

 

Director

Held in Own Name, or Concert Party

Number of 1p Ordinary Shares

Notes

Jamie Gibson

Own Name

35,000,000 (64.58%)

Entitlement under the Long Term Incentive Plan of Plethora Solutions Holdings plc, under which shares will be granted on a change of control of Plethora Solutions Holdings plc.

 

 

James Mellon, a director of Regent Pacific Group Limited, has the following relevant securities in Plethora Solutions Holdings plc:

 

Party

Number of Convertible Loan Notes 2020

Notes

James Mellon

17,000,000 (100.00%)

Convertible loan in the amount of £340,000, repayable on 31 March 2020, with an option to elect for this loan to be repaid in shares in Plethora Solutions Holdings plc at 2 pence.

 

Galloway Limited, a concert party of Regent Pacific Group Limited via James Mellon, has the following relevant securities in Plethora Solutions Holdings plc:

 

Party

Number of Galloway Warrants 2023

Notes

Galloway Limited

54,118,431 (100.00%)

Warrants to subscribe for 5 per cent. of the fully diluted share capital of Plethora Solutions Holdings plc, excisable at 1.25 pence on or before 31 March 2023. A company wholly owned by a settlement, of which James Mellon is a beneficiary.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

20 January 2016

Contact name:

Stella Fung

Telephone number:

+852 2514 6188

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEGMGMMVLDGVZM
Date   Source Headline
15th Mar 20132:57 pmRNSHolding(s) in Company
25th Feb 201311:07 amRNSStrategic review of The Urology Company Limited
14th Feb 20137:00 amRNSFinancing Update
5th Feb 201312:24 pmRNSRelated Party Transaction
5th Feb 20138:19 amRNSFinancing Update
7th Nov 20124:58 pmRNSHolding(s) in Company
28th Sep 20127:00 amRNSHalf Yearly Report
29th Jun 201211:55 amRNSReport & Accounts
29th Jun 20127:00 amRNSTotal Voting Rights
26th Jun 20125:15 pmRNSHolding(s) in Company
15th Jun 20124:11 pmRNSIssue of Equity - Directors' Interest
14th Jun 201212:05 pmRNSSubscription of Shares
24th Apr 201212:00 pmRNSChange of Registered Office
29th Mar 20127:00 amRNSPreliminary Results
15th Mar 20127:00 amRNSPSD502 Regulatory Submission Update
23rd Jan 20127:01 amRNSTrading Statement
20th Jan 20127:00 amRNSProduct Launch
6th Jan 20127:00 amRNSDirectorate Change
19th Dec 20117:00 amRNSProduct Update
31st Oct 20116:04 pmRNSTotal Voting Rights
14th Oct 20111:23 pmRNSResult of General Meeting
30th Sep 20117:00 amRNSHalf Yearly Report
28th Sep 20117:00 amRNSProposed Financing & Reduction of Debt
28th Sep 20117:00 amRNSAmendment to PSD502 Agreements
25th Jul 20117:00 amRNSStriant® SR commercial update
20th Jul 201112:09 pmRNSTrading Update
6th Jul 20111:24 pmRNSResult of AGM
24th Jun 20112:36 pmRNSReport and Accounts
20th Jun 20117:00 amRNSRe Agreement
9th Jun 201110:00 amRNSResignation of Dr Steven Powell
4th May 20117:00 amRNSExpansion of UK Sales Force
3rd May 20113:48 pmRNSTotal Voting Rights
28th Apr 20114:02 pmRNSDirector/PDMR Shareholding
28th Apr 20112:00 pmRNSHolding(s) in Company
20th Apr 20114:05 pmRNSResult of EGM
15th Apr 20117:00 amRNSHyalofemme Product Update
1st Apr 20117:00 amRNSFinal Results
1st Apr 20117:00 amRNSPlacing
14th Mar 20117:00 amRNSRe Agreement
11th Mar 20112:52 pmRNSDirectorate Change
24th Feb 201112:02 pmRNSHolding(s) in Company
3rd Feb 20119:48 amRNSDirector/PDMR Shareholding
3rd Feb 20117:00 amRNSTrading Update
28th Jan 20113:47 pmRNSHolding(s) in Company
22nd Dec 20104:42 pmRNSHolding(s) in Company
20th Dec 201010:24 amRNSResult of Meeting
20th Dec 20107:00 amRNSExpansion of Product Portfolio
3rd Dec 20107:05 amRNSBusiness Update & Proposed Placing
3rd Dec 20107:00 amRNSProduct Update
17th Nov 20107:01 amRNSLaunch of 3 New Products

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.